Evidence map›Paper›PMID 26748650›Full record

ReviewCurrent cardiology reports2016

25 by 25: Achieving Global Reduction in Cardiovascular Mortality.

Sagar Dugani, Thomas A Gaziano

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current cardiology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Management of Hypertension in the Asia-Pacific Region: A Structured Review.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024
    Review
  16. Observational
  17. Article
  18. Review
  19. Oxidative Stress, Antioxidants and Hypertension.Antioxidants (Basel, Switzerland) · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sagar DuganiDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, USA. sagar.dugani@utoronto.ca.
Thomas A GazianoDivision of Cardiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, USA. tgaziano@partners.org.

Funding

Global Cardiovascular Disease Policy Model for Screening Prevention and TreatmentR01HL104284 · NHLBI · HARVARD SCHOOL OF PUBLIC HEALTH · PI GAZIANO, THOMAS A · 2010 to 2014
$2.5M
NHLBI NIH HHS R01 HL104284
6 · The paper itself

Abstract

Four non-communicable diseases-cardiovascular disease, chronic respiratory disease, diabetes mellitus, and cancer-account for over 60 % of all deaths globally. In recognition of this significant epidemic, the United Nations set forth a target of reducing the four major NCDs by 25 % by 2025. Cardiovascular disease alone represents half of these deaths and is the leading cause of death globally, representing as much as 60 % of all deaths in regions such as Eastern Europe. In response, the WHO set specific targets on conditions and risk factors and changes in the health systems structure in order to achieve the goals. The focus was set on lifestyle risk factors-physical activity, salt-intake, and tobacco-and established conditions-obesity, hypertension, and diabetes mellitus. Health system efforts to improve medical treatment of high risk are encouraged. Efforts to achieve the goal are being promoted by leading international CVD organizations.

Indexed as

Risk Reduction BehaviorSmoking PreventionCardiovascular DiseasesDiabetes MellitusGlobal HealthHealth Knowledge, Attitudes, PracticeHumansHypertensionObesityRisk FactorsSmokingSodium Chloride, DietaryUnited NationsSodium Chloride, DietaryCardiovascularGlobalIschemic heart diseaseMortalityPrevention

Identifiers

PMID26748650
PMCPMC4797715

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.